319 related articles for article (PubMed ID: 23381977)
1. Diagnosis and treatment of invasive fungal infections focus on liposomal amphotericin B.
Lacerda JF; Oliveira CM
Clin Drug Investig; 2013 Feb; 33 Suppl 1():S5-14. PubMed ID: 23381977
[TBL] [Abstract][Full Text] [Related]
2. Patients at high risk of invasive fungal infections: when and how to treat.
Rüping MJ; Vehreschild JJ; Cornely OA
Drugs; 2008; 68(14):1941-62. PubMed ID: 18778118
[TBL] [Abstract][Full Text] [Related]
3. Focus on fungal infections.
MacDougall DS
J Int Assoc Physicians AIDS Care; 1997 Jul; 3(7):27-32. PubMed ID: 11364470
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology, diagnosis and treatment of fungal respiratory infections in the critically ill patient.
Garnacho-Montero J; Olaechea P; Alvarez-Lerma F; Alvarez-Rocha L; Blanquer J; Galván B; Rodriguez A; Zaragoza R; Aguado JM; Mensa J; Solé A; Barberán J
Rev Esp Quimioter; 2013 Jun; 26(2):173-88. PubMed ID: 23817660
[TBL] [Abstract][Full Text] [Related]
5. Invasive fungal infections: the challenge continues.
Gullo A
Drugs; 2009; 69 Suppl 1():65-73. PubMed ID: 19877737
[TBL] [Abstract][Full Text] [Related]
6. An epidemic of invasive fungal infection in a stem cell transplant unit; response to high-dose liposomal amphotericin B.
Ryan C; McNicholsan S; O'Connell B; Forde S; Keoghan M; McCann SR
Hematol J; 2004; 5(6):548-51. PubMed ID: 15570304
[No Abstract] [Full Text] [Related]
7. Presentation of the PATH Alliance registry for prospective data collection and analysis of the epidemiology, therapy, and outcomes of invasive fungal infections.
Horn DL; Fishman JA; Steinbach WJ; Anaissie EJ; Marr KA; Olyaei AJ; Pfaller MA; Weiss MA; Webster KM; Neofytos D
Diagn Microbiol Infect Dis; 2007 Dec; 59(4):407-14. PubMed ID: 17888614
[TBL] [Abstract][Full Text] [Related]
8. Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections.
Moen MD; Lyseng-Williamson KA; Scott LJ
Drugs; 2009; 69(3):361-92. PubMed ID: 19275278
[TBL] [Abstract][Full Text] [Related]
9. Fungal infections in iatrogenically compromised hosts.
Rex JH; Walsh TJ; Anaissie EJ
Adv Intern Med; 1998; 43():321-71. PubMed ID: 9506187
[No Abstract] [Full Text] [Related]
10. [Systemic mycotic infections].
Meunier F
Recenti Prog Med; 1990 Jan; 81(1):18-22. PubMed ID: 2173078
[TBL] [Abstract][Full Text] [Related]
11. Fungal complications of transplantation: diagnosis, treatment and prevention.
Warnock DW
J Antimicrob Chemother; 1995 Oct; 36 Suppl B():73-90. PubMed ID: 8601545
[TBL] [Abstract][Full Text] [Related]
12. New developments in the diagnosis and management of invasive fungal infections.
De Marie S
Haematologica; 2000 Jan; 85(1):88-93. PubMed ID: 10629598
[TBL] [Abstract][Full Text] [Related]
13. Management of mycoses in surgical patients -- review of the literature.
Holzheimer RG; Dralle H
Eur J Med Res; 2002 May; 7(5):200-26. PubMed ID: 12069912
[TBL] [Abstract][Full Text] [Related]
14. [Diagnostics and therapy for invasive fungal infections in an intensive care unit].
Koch S; Haefner H; Huenger F; Haase G; Wildberger J; Lemmen SW
Anaesthesist; 2005 Oct; 54(10):1047-64; quiz 1065-6. PubMed ID: 16211405
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.
Neofytos D; Horn D; Anaissie E; Steinbach W; Olyaei A; Fishman J; Pfaller M; Chang C; Webster K; Marr K
Clin Infect Dis; 2009 Feb; 48(3):265-73. PubMed ID: 19115967
[TBL] [Abstract][Full Text] [Related]
16. [Epidemiology and therapy of mycotic infections in immunocompromised host with special regard to the role of lipid formulations of amphotericin B].
Viscoli C; Castagnola E
Recenti Prog Med; 1999 Oct; 90(10):545-57. PubMed ID: 10592741
[TBL] [Abstract][Full Text] [Related]
17. Randomized PCR-based therapy and risk factors for invasive fungal infection following reduced-intensity conditioning and hematopoietic SCT.
Blennow O; Remberger M; Klingspor L; Omazic B; Fransson K; Ljungman P; Mattsson J; Ringdén O
Bone Marrow Transplant; 2010 Dec; 45(12):1710-8. PubMed ID: 20190840
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients.
Neofytos D; Fishman JA; Horn D; Anaissie E; Chang CH; Olyaei A; Pfaller M; Steinbach WJ; Webster KM; Marr KA
Transpl Infect Dis; 2010 Jun; 12(3):220-9. PubMed ID: 20113459
[TBL] [Abstract][Full Text] [Related]
19. Invasive fungal infections.
Hope W; Natarajan P; Goodwin L
Clin Med (Lond); 2013 Oct; 13(5):507-10. PubMed ID: 24115712
[No Abstract] [Full Text] [Related]
20. Diagnosis and treatment of invasive fungal infections in the cancer patient: recent progress and ongoing questions.
Kontoyiannis DP; Patterson TF
Clin Infect Dis; 2014 Nov; 59 Suppl 5(Suppl 5):S356-9. PubMed ID: 25352631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
